Ausgabe 4/2011
Inhalt (14 Artikel)
Gender aspects in haematology and oncology: Overview and own observations in lung cancer
- Leading article
M. Fiegl, C. Thöni, M. Hochleitner
Gender differences in quality of life in patients with haematological malignancies
- Short review
M. Sztankay, J. Giesinger, B. Holzner
Gender and haemato-oncology: Aspects of pharmacokinetics and pharmacodynamics
- Short review
R. M. Mader, M. Fiegl
Cancer in the elderly and gender aspects – situation in Tyrol
- Short review
S. Geiger-Gritsch, H. Mühlböck, L. Harrasser, W. Oberaigner
Molecular oncology in lung cancer – between biomarkers and clinical application. Relevance of the Ras–Raf–MEK–ERK pathway
- Review
W. Berger, A. Pircher, M. Sibilia, L. Bubendorf, M. Filipits, M. Fiegl, M. Früh, C. Manegold, H. Popper, W. Hilbe
A histology-based algorithm in the molecular diagnosis of mutations of the epidermal growth factor receptor (EGFR)–in non-small-cell lung cancer (NSCLC)*
- Consensus report
H. Popper, F. Wrba, U. Gruber-Mösenbacher, W. Hulla, R. Pirker, W. Hilbe, M. Studnicka, A. Mohn-Staudner, F. Ploner
Surgical topics of interest at the 14th World Conference on Lung Cancer
- Congress report
F. Augustin, J. Bodner
The role of radiochemotherapy in the multimodal treatment of pancreatic ductal adenocarcinoma: Standard procedure or individual decision?
- Short review
R. Jäger, A. de Vries
Treatment of invasive aspergillosis in cancer patients
- Short review
J. Auberger, G. Russ, R. Greil, A. Egle
